{"id":6974,"date":"2025-05-28T11:06:03","date_gmt":"2025-05-28T09:06:03","guid":{"rendered":"https:\/\/beigen.vipdev.lndo.site\/us\/?post_type=pipelines&p=6974"},"modified":"2025-05-28T11:06:03","modified_gmt":"2025-05-28T09:06:03","slug":"xaluritamig%e2%81%b7-steap1-x-cd3-bsab","status":"publish","type":"pipelines","link":"https:\/\/beonemedaffairs.com\/us\/pipelines\/6974\/xaluritamig%e2%81%b7-steap1-x-cd3-bsab\/","title":{"rendered":"Xaluritamig\u2077 (STEAP1 x CD3 BsAb)"},"content":{"rendered":"","protected":false},"template":"","meta":{"_acf_changed":false,"editor_notices":[]},"class_list":["post-6974","pipelines","type-pipelines","status-publish","hentry","molecule-xaluritamig","compound_type-bi-tri-specific"],"acf":{"indications_repeater":[{"indication":"mCRPC","disease_state":null,"phase":1,"countries":[],"status":"planned"}],"cancer_type":["46"],"compound_type":418,"custom_link":null},"_links":{"self":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/pipelines\/6974","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/pipelines"}],"about":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/types\/pipelines"}],"acf:term":[{"embeddable":true,"taxonomy":"compound_type","href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/compound_type\/418"}],"wp:attachment":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/media?parent=6974"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}